Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.
This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.
Why this paper is included
Supporting source evidence:
Thirty-four (16.9%) participants progressed to respiratory failure with the need of mechanical ventilation, and 16 (8%) died (15 in-hospital and one during the 30-day follow-up after discharge) (Table 2).Laboratory results according to clinical outcomesVariables(n. %)Total(n = 201)Mechanical Ventilation (n = 34)No MV(n = 167)pDeath(n = 16)No death(n = 185)pLaboratory tests abnormalities (in quartiles) Higher CRP (mg/L)51 (25.4)19 (55.9)32 (19.2)< 0.0019 (56.3)42 (22.7)0.006 Higher IL-6 (pg/mL)49 (24.4)15 (44.1)34 (20.4)0.0049 (56.3)40 (21.6)0.004 Higher d-Dimer (ng/mL)51 (25.4)18 (52.9)33 (19.8)< 0.00110 (62.5)41 (22.2)0.001 Higher ALT (U/mL)51 (25.4)9 (26.5)42 (25.1)0.5123 (18.8)48 (25.9)0.384Higher AST (U/mL)51 (25.4)16 (47.1)35 (21.0)0.0026 (37.5)45 (24.3)0.191 Lower Hemoglobin (g/mL)51 (25.4)18 (52.9)33 (19.8)< 0.00110 (62.5)41 (22.2)0.001 Higher Leucocytes (/μL)49 (24.4)12 (35.3)37 (22.2)0.0827 (43.8)42 (22.7)0.063 Higher Creatinine (mg/dL)50 (24.9)14 (41.2)36 (21.6)0.0179 (56.3)41 (22.2)0.005 Higher Myoglobin (ng/mL)50 (25.0)19 (55.9)31 (18.7)< 0.0019 (56.3)41 (22.3)0.005 Lower Vitamin D (ng/dL)48 (23.9)45 (26.9)3 (8.8)0.0262 (12.5)46 (24.9)0.215 Lower Lymphocytes (/μL)49 (24.4)17 (50.0)32 (19.2)< 0.0016 (37.5)43 (23.2)0.165Laboratories variables (means ± SD) CRP (mg/L)54.88 (58.92)94.97 (68.87)46.71 (53.32)< 0.00198.28 (67.97)51.12 (56.73)0.002 IL-6 (pg/mL)39.50 (60.58)83.87 (99.40)30.46 (44.41)< 0.00196.58 (85.19)34.56 (55.59)0.000 D-Dimer (ng/mL)886.16 (1002.79)1426.05 (1432.77)776.25 (855.34)0.0021382.06 (977.41)843.28 (995.95)0.039 ALT (U/mL)39.45 (33.84)37.88 (27.89)39.77 (34.99)0.76737.00 (33.70)39.67 (33.94)0.763 AST (U/mL)35.20 (23.53)47.00 (30.85)32.80 (21.06)0.00150.87 (39.25)33.84 (21.29)0.005 Hemoglobin (g/mL)12.77 (1.94)11.73 (2.16)12.98 (1.83)0.00111.23 (2.18)12.90 (1.86)0.001 Leucocytes (/μL)7012.95 (3410.39)8552.08 (3246.08)6699.60 (3366.65)0.0049013.12 (3116.15)6839.97 (3387.12)0.014 Creatinine (mg/dL)1.05 (0.63)1.31 (0.865)1.00 (0.56)0.0091.27 (0.48)1.03 (0.64)0.146 Myoglobin (ng/mL)68.25 (147.88)163.19 (328.13)48.81 (51.03)< 0.001135.82 (180.03)62.38 (143.84)0.057 Vitamin D (ng/dL)33.01 (15.47)28.41 (9.98)33.95 (16.22)0.05729.62 (9.89)33.30 (15.84)0.362 Lymphocytes (/μL)1019.56 (599.60)697.61 (403.83)1085.10 (612.52)0.001863.62 (427.83)1033.04 (611.20)0.279Legend: C-reactive protein (CRP), interleukin 6 (IL-6), alanine transaminase (ALT), aspartate aminotransferase (AST)
Source: Results. View original paper
Relevance classification does not establish study quality, causation or editorial approval.
Study design Cohort study.
Cohort study
Examines exposures and outcomes over time within a defined group.
Meta-analysis unclear · Blinding unclear / not reported · Human research reported
How this paper was classified
Automatic source-based classification; awaiting editorial verification. This is not a quality score.
Chronic diseases, chest computed tomography, and laboratory tests as predictors of severe respiratory failure and death in elderly Brazilian patients hospitalized with COVID-19: a prospective cohort study
Source: Article title.
Participants were followed during their entire hospital stay and up to 30 days after hospital discharge.
Source: Methods.
What the study types mean
- Systematic review
- Uses explicit methods to identify, assess and summarise research on a defined question.
- Scoping review
- Maps the extent and characteristics of research on a topic.
- Narrative review
- Discusses existing research; systematic-review methods have not been established by this classification.
- Review / evidence synthesis
- Reviews existing research; the exact review methods need further assessment.
- Randomised controlled trial
- Assigns participants or groups to comparison interventions by chance.
- Non-randomised intervention study
- Examines an intervention without random allocation.
- Cohort study
- Examines exposures and outcomes over time within a defined group.
- Case-control study
- Compares people with an outcome against people without it, examining exposures.
- Cross-sectional study
- Examines a population at a particular point in time.
- Observational study
- Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
- Case report
- Describes an individual case.
- Case series
- Describes a group of individual cases.
- Secondary analysis
- Analyses existing study data; this paper is not automatically another independent trial.
- Laboratory study
- Investigates biological processes in a laboratory setting.
- Qualitative study
- Examines experiences or meanings using qualitative methods.
- Genetic instrumental-variable study
- Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
- Study protocol
- Describes planned methods and is not evidence that the planned study has reported results.
- Multiple reported designs
- More than one design is explicitly reported; examine the supporting methods.
- Study design awaiting verification
- The available source does not establish a sufficiently clear study design.
Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.
Abstracts
Chronic diseases, chest computed tomography, and laboratory tests as predictors of severe respiratory failure and death in elderly Brazilian patients hospitalized with COVID-19: a prospective cohort study
Cohort study · BMC Geriatrics · 2022
Original publication title
Chronic diseases, chest computed tomography, and laboratory tests as predictors of severe respiratory failure and death in elderly Brazilian patients hospitalized with COVID-19: a prospective cohort study
© The Author(s) 2022
Original publication · Publisher record · CC BY 4.0 · CC0
Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.
At a glance
Abstract: What objectives does the paper state?
To determine the association of chronic diseases, chest computed tomography (CT), and laboratory tests with severe respiratory failure and mortality in older adults hospitalized with COVID-19.
Source: ObjectiveAbstract: What methods does the paper describe?
This was a prospective cohort with 201 hospitalized older adults with COVID-19. Chronic diseases, chest CT, laboratory tests, and other data were collected within the first 48 h of hospitalization. Outcomes were progression to severe respiratory failure with the need of mechanical ventilation (SRF/MV) and death.
Source: MethodAbstract: Results
The mean age was 72.7 ± 9.2 years, and 63.2% were men. SRF/MV occurred in 16.9% (p < 0.001), and death occurred in 8%. In the adjusted regression analyses, lung involvement over 50% [odds ratio (OR): 3.09 (1.03 to 9.28; 0.043)], C-reactive protein (CRP) > 80 ng/mL [OR: 2.97 (0.99 to 8.93; 0.052)], Vitamin D < 40 ng/mL [OR: 6.41 (1.21 to 33.88; 0.029)], and hemoglobin < 12 g/mL [OR: 3.32 (1.20 to 9.20; 0.020)] were independent predictors for SFR/MV, while chronic atrial fibrillation [OR: 26.72 (3.87 to 184.11; 0.001)], cancer history [OR:8.32 (1.28 to 53.91; 0.026)] and IL-6 > 40 pg/mL [OR:10.01 (1.66 to 60.13; 0.012)] were independent predictors of death.
Source: ResultsAbstract: Conclusion
In hospitalized older adults with COVID-19, tomographic pulmonary involvement > 50%, anemia, vitamin D below 40 ng/mL, and CRP above 80 mg/L were independent risk factors for progression to SRF/MV. The presence of chronic atrial fibrillation, previous cancer, IL-6 > 40 pg/mL, and anemia were independent predictors of death.
Source: ConclusionAuthors’ abstract
Background
The primary risk factors for severe respiratory failure and death in the elderly hospitalized with COVID-19 remain unclear.
Objective
To determine the association of chronic diseases, chest computed tomography (CT), and laboratory tests with severe respiratory failure and mortality in older adults hospitalized with COVID-19.
Method
This was a prospective cohort with 201 hospitalized older adults with COVID-19. Chronic diseases, chest CT, laboratory tests, and other data were collected within the first 48 h of hospitalization. Outcomes were progression to severe respiratory failure with the need of mechanical ventilation (SRF/MV) and death.
Results
The mean age was 72.7 ± 9.2 years, and 63.2% were men. SRF/MV occurred in 16.9% (p < 0.001), and death occurred in 8%. In the adjusted regression analyses, lung involvement over 50% [odds ratio (OR): 3.09 (1.03 to 9.28; 0.043)], C-reactive protein (CRP) > 80 ng/mL [OR: 2.97 (0.99 to 8.93; 0.052)], Vitamin D < 40 ng/mL [OR: 6.41 (1.21 to 33.88; 0.029)], and hemoglobin < 12 g/mL [OR: 3.32 (1.20 to 9.20; 0.020)] were independent predictors for SFR/MV, while chronic atrial fibrillation [OR: 26.72 (3.87 to 184.11; 0.001)], cancer history [OR:8.32 (1.28 to 53.91; 0.026)] and IL-6 > 40 pg/mL [OR:10.01 (1.66 to 60.13; 0.012)] were independent predictors of death.
Conclusion
In hospitalized older adults with COVID-19, tomographic pulmonary involvement > 50%, anemia, vitamin D below 40 ng/mL, and CRP above 80 mg/L were independent risk factors for progression to SRF/MV. The presence of chronic atrial fibrillation, previous cancer, IL-6 > 40 pg/mL, and anemia were independent predictors of death.
Publication and source details
Original title: Chronic diseases, chest computed tomography, and laboratory tests as predictors of severe respiratory failure and death in elderly Brazilian patients hospitalized with COVID-19: a prospective cohort study
Alberto Frisoli Junior; Elaine Azevedo; Angela Tavares Paes; Eliene Lima; João Carlos Campos Guerra; Sheila Jean Mc Neill Ingham
BMC Geriatrics · 2022
© The Author(s) 2022https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.Repository JATS snapshot; version as supplied
Source retrieved: 2026-11-11T10:51:26.173933+00:00
DOI: 10.1186/s12877-022-02776-3 · PMC8851839